Skip to content
Loading…
The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.